Imidex announced that it received FDA 510(k) clearance for its flagship, AI-powered VisiRad XR software product.
VisiRad XR analyzes chest X-rays and highlights possible lung nodules and masses. It employs state-of-the-art machine learning techniques developed using curated training data from around the world.
According to Imidex, the software offers clinicians a closer look at often-overlooked lung lesions. This could enable the identification of future lung cancers in outpatient and emergency department settings.
“Radiologists are looking for solutions to help elevate their performance and reduce burnout,” said Dr. Raj Chopra, Imidex chief medical officer. “With volumes increasing and staffing decreasing, tools like VisiRad XR are beneficial not only for patient care, but for helping radiologists continue to practice to their full potential.”
More about the Imidex VisiRad XR solutionVisiRad XR offers a turnkey solution that plugs into the curre…